SCHEMBL10028196

SCHEMBL10028196

c1ccc2c(-c3cc4ccc5oc6ccc(-c7ccc8oc9ccc%10cc(-c%11cccc%12ccccc%11%12)cc%11oc%12ccc7c8c%12-c9c%10%11)c7ccc8oc(c3)c4c5-c8c67)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.38
MAOB P27338 1/20 0.38
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
AHR P35869 5/20 0.35
CYP1A2 P05177 2/20 0.35
FYN P06241 2/20 0.35
CYP1A1 P04798 1/20 0.35
MAPK3 P27361 1/20 0.35
PAX8 Q06710 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028088 0.93 MEN1 (0.40) MAOAMAOBMEN1MAPTKMT2A
SCHEMBL10028197 0.88 AHR (0.38) MAOAMEN1MAPTKMT2AALDH1A1
SCHEMBL10028105 0.86 MAOA (0.43) MAOAMAOBMEN1MAPTKMT2A
SCHEMBL10028146 0.80 MCL1 (0.38) MAOAMAOBMEN1MAPTKMT2A
SCHEMBL10028089 0.80 AHR (0.37) HPGDAHRCYP1A2FYNCYP1A1
SCHEMBL10028086 0.80 CYP1A2 (0.37) MAOAMAPTKMT2AALDH1A1HPGD
SCHEMBL10028107 0.79 GSTP1 (0.44) ALDH1A1HPGDHSD17B10AHRCYP1A2
SCHEMBL10028200 0.78 ALDH1A1 (0.36) MAOAALDH1A1HPGDHSD17B10AHR
SCHEMBL27013053 0.78 L3MBTL1 (0.40) MAOAMAOBMEN1MAPTKMT2A
SCHEMBL18711181 0.78 CYP1A2 (0.44) MAOAMAOBALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
WO-2008011964-A1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 MAOA 469/4885MAOB 498/4885MEN1 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.